Go Pro

MarketBeat Instant News Alerts

MarketBeat Instant News Alerts - Page 115

Constellation Software logo with Technology background
September 30, 2026 2:29 AM ET

Constellation Software Inc. (TSE:CSU) Stock Rated "Moderate Buy" by Sell-Side Analysts

TSE:CSU
Read Constellation Software Inc. (TSE:CSU) Stock Rated "Moderate Buy" by Sell-Side Analysts
Federated Hermes logo with Finance background
September 30, 2026 2:29 AM ET

Federated Hermes, Inc. (NYSE:FHI) Stock Has Average Target Price of $57.40

NYSE:FHI
Read Federated Hermes, Inc. (NYSE:FHI) Stock Has Average Target Price of $57.40
Moelis & Company logo with Finance background
September 30, 2026 2:29 AM ET

Moelis & Company (NYSE:MC) Stock Has Consensus Target Price of $73.62 According to Brokerages

NYSE:MC
Read Moelis & Company (NYSE:MC) Stock Has Consensus Target Price of $73.62 According to Brokerages
Stride logo with Consumer Discretionary background
September 30, 2026 2:29 AM ET

Stride, Inc. (NYSE:LRN) Stock Rated "Hold" by Wall Street Analysts

NYSE:LRN
Read Stride, Inc. (NYSE:LRN) Stock Rated "Hold" by Wall Street Analysts
Progress Software logo with Technology background
September 30, 2026 2:29 AM ET

Progress Software Corporation (NASDAQ:PRGS) Receives Consensus Recommendation of "Moderate Buy" from Analysts

NASDAQ:PRGS
Read Progress Software Corporation (NASDAQ:PRGS) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Ziff Davis logo with Communication Services background
September 30, 2026 2:29 AM ET

Ziff Davis, Inc. (NASDAQ:ZD) Receives Average Rating of "Hold" from Analysts

NASDAQ:ZD
Read Ziff Davis, Inc. (NASDAQ:ZD) Receives Average Rating of "Hold" from Analysts
Viasat logo with Technology background
September 30, 2026 2:29 AM ET

Viasat Inc. (NASDAQ:VSAT) Stock Now Rated "Moderate Buy" by Sell-Side Analysts

NASDAQ:VSAT
Read Viasat Inc. (NASDAQ:VSAT) Stock Now Rated "Moderate Buy" by Sell-Side Analysts
XPENG logo with Consumer Discretionary background
September 30, 2026 2:29 AM ET

XPENG Inc. Sponsored ADR (NYSE:XPEV) Stock Has Consensus Price Target of $22.09

NYSE:XPEV
Read XPENG Inc. Sponsored ADR (NYSE:XPEV) Stock Has Consensus Price Target of $22.09
Everplay Group logo with Communication Services background
September 30, 2026 2:20 AM ET

Everplay Group (LON:EVPL) Sets New 1-Year High - Time to Buy?

LON:EVPL
Read Everplay Group (LON:EVPL) Sets New 1-Year High - Time to Buy?
Greggs logo with Consumer Discretionary background
September 30, 2026 2:20 AM ET

Greggs (LON:GRG) Hits New 12-Month High - What's Next?

LON:GRG
Read Greggs (LON:GRG) Hits New 12-Month High - What's Next?
IP Group logo with Finance background
September 30, 2026 2:20 AM ET

IP Group (LON:IPO) Sets New 12-Month High - Still a Buy?

LON:IPO
Read IP Group (LON:IPO) Sets New 12-Month High - Still a Buy?
TeraWulf logo with Technology background
September 30, 2026 2:14 AM ET

TeraWulf Inc. (NASDAQ:WULF) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

NASDAQ:WULF
Read TeraWulf Inc. (NASDAQ:WULF) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
Maple Leaf Foods logo with Consumer Staples background
September 30, 2026 2:14 AM ET

Maple Leaf Foods Inc. (TSE:MFI) Stock Has Consensus Price Target of C$36.33

TSE:MFI
Read Maple Leaf Foods Inc. (TSE:MFI) Stock Has Consensus Price Target of C$36.33
Tenaya Therapeutics logo with Healthcare background
September 30, 2026 2:14 AM ET

Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Stock Has Average Target Price of $4.00

NASDAQ:TNYA
Read Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Stock Has Average Target Price of $4.00
Treace Medical Concepts logo with Healthcare background
September 30, 2026 2:14 AM ET

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Stock Has Consensus Target Price of $5.17 According to Brokerages

NASDAQ:TMCI
Read Treace Medical Concepts, Inc. (NASDAQ:TMCI) Stock Has Consensus Target Price of $5.17 According to Brokerages
Rhythm Pharmaceuticals logo with Healthcare background
September 30, 2026 2:14 AM ET

Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Stock Has Consensus Target Price of $140.67

NASDAQ:RYTM
Read Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Stock Has Consensus Target Price of $140.67
First Hawaiian logo with Finance background
September 30, 2026 2:14 AM ET

First Hawaiian, Inc. (NASDAQ:FHB) Stock Has Average Target Price of $30.25

NASDAQ:FHB
Read First Hawaiian, Inc. (NASDAQ:FHB) Stock Has Average Target Price of $30.25
Iron Mountain logo with Real Estate background
September 30, 2026 2:14 AM ET

Iron Mountain Incorporated (NYSE:IRM) Receives Average Rating of "Moderate Buy" from Brokerages

NYSE:IRM
Read Iron Mountain Incorporated (NYSE:IRM) Receives Average Rating of "Moderate Buy" from Brokerages
Stifel Financial logo with Finance background
September 30, 2026 2:14 AM ET

Stifel Financial Corporation (NYSE:SF) Stock Has Average Price Target of $91.90 According to Brokerages

NYSE:SF
Read Stifel Financial Corporation (NYSE:SF) Stock Has Average Price Target of $91.90 According to Brokerages
Corbus Pharmaceuticals logo with Healthcare background
September 30, 2026 2:14 AM ET

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives Average Recommendation of "Moderate Buy" from Brokerages

NASDAQ:CRBP
Read Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives Average Recommendation of "Moderate Buy" from Brokerages
Aclaris Therapeutics logo with Healthcare background
September 30, 2026 2:14 AM ET

Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Stock Has Consensus Target Price of $11.33 According to Brokerages

NASDAQ:ACRS
Read Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Stock Has Consensus Target Price of $11.33 According to Brokerages
Group 1 Automotive logo with Consumer Discretionary background
September 30, 2026 2:14 AM ET

Group 1 Automotive, Inc. (NYSE:GPI) Stock Has Consensus Price Target of $360.25 According to Analysts

NYSE:GPI
Read Group 1 Automotive, Inc. (NYSE:GPI) Stock Has Consensus Price Target of $360.25 According to Analysts
Humacyte logo with Healthcare background
September 30, 2026 2:14 AM ET

Humacyte, Inc. (NASDAQ:HUMA) Stock Has Average Target Price of $6.54

NASDAQ:HUMA
Read Humacyte, Inc. (NASDAQ:HUMA) Stock Has Average Target Price of $6.54
Lakefront Biotherapeutics American Depositary Shares logo with Healthcare background
September 30, 2026 2:14 AM ET

Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT) Stock Now Rated "Moderate Buy" by Sell-Side Analysts

NASDAQ:LKFT
Read Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT) Stock Now Rated "Moderate Buy" by Sell-Side Analysts

Featured Articles and Offers

Alert Categories

All Alerts